A look at focused radiation for tumors on the optic nerve
Original title: Assessment of the Efficacy and Safety of CyberKnife Radiosurgery on Optic Nerve Sheath Meningiomas.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a small look back at people already treated, not a planned trial.
The short version
Most eyes in this small study kept or gained vision after focused radiation.
What was studied. Doctors looked back at records of 20 people with a tumor on the optic nerve covering. The 22 affected eyes were treated with stereotactic radiosurgery: Radiation aimed at a small target, in one visit or a few. There is no cutting, despite the name. See the glossary radiation, given in 5 sessions.
What they found. Vision stayed the same or got better in 20 of 22 eyes. It got better in 13 of 22 eyes and stayed steady in 7 of 22. Vision got worse in 2 of 22 eyes. Scans were checked in 14 eyes, and the tumor did not grow in any of them. No serious problems from the treatment were seen.
What this means, and what it doesn't
What it could mean: This type of focused radiation may help protect sight for people with this tumor. People with better vision at the start tended to do better. So did people treated sooner after symptoms began.
What it doesn't mean: This is not a cure, and it is not proof. It was a small look back at past records, not a planned trial. Only 20 people took part, and no other treatment was compared. Results could look different in a larger group. Ask your own care team what makes sense for you.
Source: PubMed, October 11, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.